Life Data Economics: What Genomes Mean For Healthcare Introduction: Two healthcare companies in the U.S have implemented using block chain technology to better understand and record gene sequences and appealed to create a new academic research field – life data economics. The companies are Nebula Genomics and Longenisis, both are firms working in Artificial Intelligence and Block chain technology for healthcare. Based on healthcare industry research and market reports these companies implement the usage of block chain technology for creation of a platform for management and trading of medical information on block chain data allowing their users to profit from their genomic and other types of clinical data. Nebula Genomics and Longenesis say that their work will establish two new fields. The first, “microdataeconomics,” is “the study of the value of life data that is used for drug discovery such as proteomics or data regarding the structure and activity of specific molecules, both in vitro and in vivo.” The second, “macrodataeconomics,” is “the study of the value of life data that is used to determine human health such as electronic health records and genomics.
Genomics: NHGRI defines genomic medicine as "an emerging medical discipline that involves using genomic information about an individual as part of their clinical care (e.g., for diagnostic or therapeutic decision-making) and the health outcomes and policy implications of that clinical